Saturday, March 5th 2016
| 09:00 | 10:20 |
Eradication of inhibitor by Immune Tolerance Induction (ITI): What we know and what we need to know Chair: Giovanni Di Minno (Italy) |
|
Eradication of allo-antibodies. International data Charles R.M. Hay (UK) |
||
|
Eradication of autoantibodies Andreas Tiede (Germany), Paul Knoebl (Austria) |
||
|
Italian ITI experience Giovanni Di Minno (Italy) |
||
| Discussion | ||
| 10:20 | 11:00 |
Future NIH programmes for the prevention of inhibitors Chair: Frits R. Rosendaal (the Netherlands) |
| Discussants: David Lillicrap and Frits R. Rosendaal | ||
| 11:20 | 12:00 |
Patients views and expectations: What initiatives are WFH and EHC planning for inhibitors? Pier Mannuccio Mannucci (Italy) |
|
European Hemophilia Consortium Amanda Bok (Belgium) |
||
|
World Federation of Hemophilia Alain Weill (Canada) |
||
| 12:00 | 13:00 |
Round Table Discussion: Benefit of fewer inhibitors? A formidable issue Moderator: Flora Peyvandi |
|
Conclusive remarks F. Peyvandi and P.M.Mannucci |
||
